Cadrenal Therapeutics, Inc. Common Stock ( CVKD) - Stock Earnings
CVKD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -2.7 million USD | — USD |
| 2025Q4 | -3.0 million USD | — USD |
| 2026Q1 | -2.5 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CVKD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.4 million USD | — USD |
| 2024 | -10.7 million USD | — USD |
| 2025 | -13.2 million USD | — USD |
| 2026 Est. | — | — |
CVKD
Price: $3.50
52 week price:
Earnings Per Share: -5.59 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 12.5 million